• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Orphan Drug Market to Grow at Over 10% CAGR to 2019


Pharmaceutical Executive

December 04, 2015.

Research and Markets released its report Global Orphan Drugs Market 2015-2019, forecasting the market to grow at a CAGR of 10.05% over the period 2014-2019.

Research analysts noted emerging trends in the orphan drug market are a focus on biologics, shorter drug development timelines, and the challenges of enrollment. Conducting clinical trials in rare diseases with smaller number of patients available for clinical studies is around recruiting enough patients to generate significant comparative data.


Read the full release.

Related Videos